Peter Quarg
Impact in
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological Disorders and Treatments
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
Papers in ⓘ
-
- Cholinesterase and Neurodegenerative Diseases 7
-
- Alzheimer's disease research and treatments 5
- Co-authors
- Murat Emre (2 shared papers)Jaime Kulisevsky (1 shared paper)Franck Durif (1 shared paper)Alain Robillard (1 shared paper)Dag Aarsland (1 shared paper)Werner Poewe (1 shared paper)Teus van Laar (1 shared paper)Erik Ch. Wolters (1 shared paper)
- Journals
- Alzheimer s & Dementia (4 papers)Neurobiology of Aging (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)New England Journal of Medicine (1 paper)Statistics in Biopharmaceutical Research (1 paper)
- Partner nations
- SwitzerlandUnited StatesSweden
In The Last Decade
Peter Quarg
13 papers receiving 981 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Neurology 580
- Psychiatry and Mental health 383
- Pharmacology 249
- Complementary and alternative medicine 119
- Neurology 105
Countries citing papers authored by Peter Quarg
This map shows the geographic impact of Peter Quarg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Quarg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Quarg more than expected).
Fields of papers citing papers by Peter Quarg
This network shows the impact of papers produced by Peter Quarg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Quarg. The network helps show where Peter Quarg may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Quarg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rivastigmine for Dementia Associated with Parkinson's Disease Hit paper breakdown → | 2004 | 793 |
| 2 | 2005 | 70 | |
| 3 | 2004 | 48 | |
| 4 | 2004 | 43 | |
| 5 | 2005 | 42 | |
| 6 | 2017 | 16 | |
| 7 | 2019 | 14 | |
| 8 | 2020 | 6 | |
| 9 | 2019 | 3 | |
| 10 | 2011 | 3 | |
| 11 | 2010 | 2 | |
| 12 | 2004 | 2 | |
| 13 | 2012 | 1 |
About Peter Quarg
Peter Quarg is a scholar working on Pharmacology, Physiology, Psychiatry and Mental health, Molecular Biology and Cognitive Neuroscience, having authored 13 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (7 papers), Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (5 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Statistical Methods in Clinical Trials (2 papers), Functional Brain Connectivity Studies (2 papers), HIV Research and Treatment (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Neurology (580 citations), Psychiatry and Mental health (383 citations), Pharmacology (249 citations), Complementary and alternative medicine (119 citations) and Neurology (105 citations). Peter Quarg has collaborated with scholars based in Switzerland, United States and Sweden. Frequent co-authors include Murat Emre, Jaime Kulisevsky, Franck Durif, Alain Robillard, Dag Aarsland, Werner Poewe, Teus van Laar, Erik Ch. Wolters, Andrew Lees and Peter Paul De Deyn. Their work appears in journals such as Alzheimer s & Dementia, Neurobiology of Aging, CPT Pharmacometrics & Systems Pharmacology, New England Journal of Medicine and Statistics in Biopharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.